Skip to content
YouTube· Osmosis · YouTube·· 14 hours agoScore23

Osmosis Explains Biliary Atresia: Types, Clinical Features, Diagnosis and Treatment

In brief

Biliary atresia is a disease in which extrahepatic bile duct obstruction causes cholestasis, progressive fibrosis and eventually cirrhosis. It has a fetal form, associated with congenital anomalies, and a perinatal form with onset at 2 to 6 weeks of age. Findings include elevated conjugated bilirubin, progressive jaundice, acholic stools and failure to thrive; diagnosis relies on laboratory tests and imaging. The main treatment is the Kasai portoenterostomy, with liver transplantation needed in late-stage disease.

Key points

Osmosis explains biliary atresia: extrahepatic bile duct obstruction causes cholestasis, fibrosis, and cirrhosis; classified into fetal and perinatal types.

  • Definition: partial or complete obstruction of the extrahepatic bile ducts prevents bile outflow; the resulting cholestasis triggers inflammation and progressive fibrosis up to cirrhosis.
  • Two types: fetal type (bile duct developmental abnormality, often associated with congenital anomalies such as intestinal malrotation, cardiac defects, interrupted inferior vena cava, and polysplenia; jaundice present at birth); perinatal type (more common, suspected to be triggered by virus/toxin-induced abnormal immune response, symptoms onset at 2–6 weeks of age).
  • Pathology: cholestasis → hepatocyte swelling, feathery degeneration → fibroblast activation, collagen deposition, bridging fibrosis.
  • Presentation: conjugated bilirubin entering the blood causes progressive jaundice, acholic stools, fat malabsorption, and failure to thrive.
  • Diagnosis: laboratory tests (elevated conjugated bilirubin, distinguishing it from other neonatal jaundice) plus imaging (absent/abnormal gallbladder, tracer entering the liver but not the intestine); main treatment is surgery (Kasai hepatoportoenterostomy), with liver transplantation needed if intrahepatic bile ducts are involved in late stages.

Source: YouTube

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org